Lipid-lowering pharmacotherapy and socioeconomic status: atherosclerosis risk in communities (ARIC) surveillance study

BACKGROUND: Lipid-reduction pharmacotherapy is often employed to reduce morbidity and mortality risk for patients with dyslipidemia or established cardiovascular disease. Associations between socioeconomic factors and the prescribing and use of lipid-lowering agents have been reported in several dev...

Descripción completa

Detalles Bibliográficos
Autores principales: Kitzmiller, Joseph P, Foraker, Randi E, Rose, Kathy M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3663719/
https://www.ncbi.nlm.nih.gov/pubmed/23688340
http://dx.doi.org/10.1186/1471-2458-13-488

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3663719/
https://www.ncbi.nlm.nih.gov/pubmed/23688340
http://dx.doi.org/10.1186/1471-2458-13-488

Ejemplares similares